Global Ursodeoxycholic Acid Market 2016 - ICE, Dipharma Francis, PharmaZell, Mitsubishi Tanabe Pharma, Daewoong Bio, Changde Yungang, Suzhou Tianlu, Zhongshan Belling, Linyi Tianli

Ursodeoxycholic acid, also known as ursodiol (USAN) and the abbreviation UDCA, from the root-word for bear urso, as bear bile contains the substance, is one of the secondary bile acids, which are metabolic byproducts of intestinal bacteria. Ursodeoxycholic acid can be chemically synthesized and is marketed under multiple trade names, including Actigall, BILIVER, Coric, Deursil, Egyurso, Udiliv, UDOXYL, Urso, Urso Forte, Ursocol, Ursofalk, Ursosan and Ursoserinox.

Primary bile acids are produced by the liver and stored in the gall bladder. When secreted into the intestine, primary bile acids can be metabolized into secondary bile acids by intestinal bacteria. Primary and secondary bile acids help the body digest fats. Ursodeoxycholic acid helps regulate cholesterol by reducing the rate at which the intestine absorbs cholesterol molecules while breaking up micelles containing cholesterol. Because of this property, ursodeoxycholic acid is used to treat (cholesterol) gallstones non-surgically. It is also used to relieve itching in pregnancy for some women who suffer obstetric cholestasis.

Download sample report at http://www.fiormarkets.com/report-detail/15416/request-sample

While some bile acids are known to be colon tumor promoters (e.g. deoxycholic acid), others such as ursodeoxycholic acid are thought to be chemopreventive, perhaps by inducing cellular differentiation and/or cellular senescence in colon epithelial cells. It is believed to inhibit apoptosis.

Ursodeoxycholic acid has also been shown experimentally to suppress immune response such as immune cell phagocytosis. Prolonged exposure and/or increased quantities of systemic (throughout the body, not just in the digestive system) ursodeoxycholic acid can be toxic.

The drug reduces cholesterol absorption and is used to dissolve (cholesterol) gallstones in patients who want an alternative to surgery. If the patient stops taking the drug the gallstones tend to recur if the condition that gave rise to their formation does not change. For these reasons, it has not supplanted surgical treatment by cholecystectomy. Also used to relieve itching in intrahepatic cholestasis of pregnancy (naltrexone may also be used).

This report provides detailed analysis of worldwide markets for Ursodeoxycholic Acid from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Ursodeoxycholic Acid market and further lays out an analysis of the factors influencing the supply/demand for Ursodeoxycholic Acid, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

Access full report at http://www.fiormarkets.com/report/global-ursodeoxycholic-acid-market-outlook-2016-2021-15416.html

Global Ursodeoxycholic Acid Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Ursodeoxycholic Acid market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Ursodeoxycholic Acid market are ICE (Italy), Dipharma Francis (Italy), PharmaZell (Germany), Mitsubishi Tanabe Pharma (Japan), Daewoong Bio (Korea), Changde Yungang (China), Suzhou Tianlu (China), Zhongshan Belling (China), Linyi Tianli (China), among others.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Ursodeoxycholic Acid industry has been provided.

Fior Markets is a leading market intelligence company that sells reports of top publishers in the technology industry.

Our extensive research reports cover detailed market assessments that include major technological improvements in the industry. Fior Markets also specializes in analyzing hi-tech systems and current processing systems in its expertise.

Contact Us
Mark Stone
Sales Manager
Phone: (201) 465-4211
Email: sales@fiormarkets.com

This release was published on openPR.